Oded Langer1, Yariv Yogev, Orli Most, Elly M J Xenakis. 1. Department of Obstetrics and Gynecology, St Luke's-Roosevelt Hospital Center, University Hospital of Columbia University, New York, NY 10019, USA. odlanger@chpnet.org
Abstract
OBJECTIVE: Untreated gestational diabetes mellitus carries significant risks of perinatal morbidity at all severity levels; treatment will enhance outcome. STUDY DESIGN: A matched control of 555 gravidas, gestational diabetes mellitus diagnosed after 37 weeks, were compared with 1110 subjects treated for gestational diabetes mellitus and 1110 nondiabetic subjects matched from the same delivery year for obesity, parity, ethnicity, and gestational age at delivery. The nondiabetic subjects and those not treated for gestational diabetes mellitus were matched for prenatal visits. RESULTS: A composite adverse outcome was 59% for untreated, 18% for treated, and 11% for nondiabetic subjects. A 2- to 4-fold increase in metabolic complications and macrosomia/large for gestational age was found in the untreated group with no difference between nondiabetic and treated subjects. Comparison of maternal size, parity, and disease severity revealed a 2- to 3-fold higher morbidity rate for the untreated groups, compared with the other groups. CONCLUSION: Untreated gestational diabetes mellitus carries significant risks for perinatal morbidity in all disease severity levels. Timely and effective treatment may substantially improve outcome.
OBJECTIVE: Untreated gestational diabetes mellitus carries significant risks of perinatal morbidity at all severity levels; treatment will enhance outcome. STUDY DESIGN: A matched control of 555 gravidas, gestational diabetes mellitus diagnosed after 37 weeks, were compared with 1110 subjects treated for gestational diabetes mellitus and 1110 nondiabetic subjects matched from the same delivery year for obesity, parity, ethnicity, and gestational age at delivery. The nondiabetic subjects and those not treated for gestational diabetes mellitus were matched for prenatal visits. RESULTS: A composite adverse outcome was 59% for untreated, 18% for treated, and 11% for nondiabetic subjects. A 2- to 4-fold increase in metabolic complications and macrosomia/large for gestational age was found in the untreated group with no difference between nondiabetic and treated subjects. Comparison of maternal size, parity, and disease severity revealed a 2- to 3-fold higher morbidity rate for the untreated groups, compared with the other groups. CONCLUSION: Untreated gestational diabetes mellitus carries significant risks for perinatal morbidity in all disease severity levels. Timely and effective treatment may substantially improve outcome.
Authors: Lu Chen; Gaia Pocobelli; Onchee Yu; Susan M Shortreed; Sarah S Osmundson; Sharon Fuller; Paige D Wartko; David Mcculloch; Susan Warwick; Katherine M Newton; Sascha Dublin Journal: Am J Perinatol Date: 2018-11-30 Impact factor: 1.862
Authors: Arthur M Baker; Sina Haeri; Carlos A Camargo; Alison M Stuebe; Kim A Boggess Journal: Diabetes Metab Res Rev Date: 2012-02 Impact factor: 4.876
Authors: Julie Brown; Nisreen A Alwan; Jane West; Stephen Brown; Christopher Jd McKinlay; Diane Farrar; Caroline A Crowther Journal: Cochrane Database Syst Rev Date: 2017-05-04
Authors: Alan T N Tita; Yinglei Lai; Mark B Landon; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George R Saade; Steve N Caritis; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa Journal: Am J Perinatol Date: 2017-07-19 Impact factor: 1.862